Hester said its Board has approved the execution of Grantin-Aid Letter Agreement for grant of Rs 60 crore in a phased manner to the company...

BBV154 is the first intranasal Covid-19 vaccine to undergo human trials in India. It has now received approval to conduct Phase 2 randomise...

Early stage trials of the vaccine candidate, BBV154, has been completed in subjects aged 18 to 60 years, and the doses were found to be wel...

Union Health Minister Mansukh Mandaviya was responding to a question on the current capacity to manufacture Covaxin and Covishield in the c...

“Mass vaccination is now the single biggest weapon to protect people from the virus. We are committed to doing everything we can to ensure ...

Soon after the government opened up vaccination for private companies, Reliance Foundation launched the vaccination drive in April, sources...

In fact, the Government of India has been supplying vaccines free of cost to the states/UTs for administration to prioritised beneficiaries...

In a written response to a question in the Rajya Sabha, Union Science and Technology Minister Jitendra Singh said Cadila Healthcare Ltd's D...

Speaking at the 44th Annual General Meeting (AGM) of RIL, Nita Ambani said, "The Covid-19 pandemic is a humanitarian crisis. It has tested ...

Department of Biotechnology Secretary Renu Swarup said a financial support of Rs 400 crore is being provided to vaccine candidates from Zyd...

He also assured all possible support and smooth approval process for the vaccine candidates which are currently under trial phase. The heal...

The DBT said it has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HGCO19,...

Indian vaccine makers such as Serum Institute and Bharat Biotech have appealed to the government to fund the expansion of their vaccine man...

The company has written to the Department of Biotechnology seeking Rs 100 crore to ramp up its manufacturing capacity.

While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass ...

The proposed mission will also look to ensure that sufficient volumes are manufactured to meet India's COVID-19 vaccine requirement and to ...

"The probable reasons are lack of manpower in inaccessible areas, inadequate access to social determinants and limited private sector engag...